Latest It Compliance News

SomnoMed has delivered a standout FY25 with revenue and EBITDA exceeding market expectations, driven by strong regional growth and operational improvements. The company is now expanding capacity and advancing its innovative Rest Assure device.

SomnoMed Limited reported a record FY25 with $111.5 million revenue and a return to positive EBITDA, marking a milestone of over one million patients treated globally. The company secured FDA clearance for its Rest Assure® compliance tracking device and provided optimistic guidance for FY26.

Invion Limited has affirmed its compliance with ASX disclosure rules following the US FDA’s granting of Orphan Drug Designation for its anal cancer treatment candidate INV043. The company detailed the timing and verification process behind its announcement.

Perpetual Limited reported a steady FY25 with underlying profit after tax of $204.1 million, revenue growth across all segments, and a net loss narrowed to $58.2 million. The firm’s refreshed strategy focuses on simplification, operational excellence, and measured growth investments amid evolving regulatory landscapes.

Telix Pharmaceuticals has received a Complete Response Letter from the FDA for its TLX250-CDx diagnostic agent, citing manufacturing concerns. The company plans immediate remediation and maintains its 2025 revenue guidance.

BetMakers Technology Group reported a 10.6% revenue decline to $85.1 million for FY25 but achieved positive adjusted EBITDA and operating cash flow for the first time, signaling a strategic turnaround.

Comms Group Limited reported a 2.1% revenue increase to $56.6 million for FY25, driven by organic growth and the strategic acquisition of TasmaNet. Despite this, underlying EBITDA declined 13.6%, reflecting investments and one-off revenue adjustments.

Eagers Automotive has reported a robust first half of 2025, with revenue climbing nearly 19% and net profit rising 8.8%, while maintaining its interim dividend at 24 cents per share.

Atlas Arteria’s half-year report for June 2025 reveals stable traffic and revenue growth across its French, German, and US toll road assets, underpinned by disciplined financial management and strategic capital investments.

Bank of Queensland announces a potential $3.8 billion equipment finance loan sale and a strategic AI partnership with Capgemini, aiming to enhance capital efficiency and cut costs. The bank updates FY25 earnings guidance while withdrawing specific FY26 targets amid ongoing uncertainty.

BNK Banking Corporation reported a strong FY25 performance, driven by margin expansion and strategic transactions that doubled non-interest income. The bank’s capital position strengthened significantly, setting the stage for future growth.

BNK Banking Corporation Limited has reported a significant turnaround in FY25, posting a statutory net profit after tax of $1.28 million, reversing a $6.7 million loss in FY24. The bank’s strategic focus on higher-margin lending and diversified income streams underpinned this recovery.